Iovance Biotherapeutics, Inc. (IOVA)
Iovance Biotherapeutics Market Cap: 1.096B for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 74.72M |
| Lantheus Holdings, Inc. | 4.454B |
| iRhythm Technologies, Inc. | 5.753B |
| Day One Biopharmaceuticals, Inc. | 941.02M |
| Perspective Therapeutics, Inc. | 204.43M |
Market Cap Related Metrics
| PS Ratio | 3.654 |
| Price to Book Value | 1.560 |
| Price | 2.76 |
| Earnings Yield | -43.55% |